Logo image of ICU

SEASTAR MEDICAL HOLDING CORP (ICU) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ICU - US81256L2034 - Common Stock

0.2631 USD
+0.02 (+9.62%)
Last: 1/2/2026, 8:00:02 PM
0.2697 USD
+0.01 (+2.51%)
After Hours: 1/2/2026, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, ICU scores 3 out of 10 in our fundamental rating. ICU was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While ICU seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ICU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ICU has reported negative net income.
In the past year ICU has reported a negative cash flow from operations.
In the past 5 years ICU always reported negative net income.
In the past 5 years ICU always reported negative operating cash flow.
ICU Yearly Net Income VS EBIT VS OCF VS FCFICU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

ICU has a Return On Assets of -87.99%. This is in the lower half of the industry: ICU underperforms 76.22% of its industry peers.
ICU has a worse Return On Equity (-119.20%) than 64.86% of its industry peers.
Industry RankSector Rank
ROA -87.99%
ROE -119.2%
ROIC N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICU Yearly ROA, ROE, ROICICU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

ICU has a better Gross Margin (95.35%) than 99.46% of its industry peers.
The Profit Margin and Operating Margin are not available for ICU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICU Yearly Profit, Operating, Gross MarginsICU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for ICU has been increased compared to 1 year ago.
Compared to 1 year ago, ICU has an improved debt to assets ratio.
ICU Yearly Shares OutstandingICU Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ICU Yearly Total Debt VS Total AssetsICU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

ICU has an Altman-Z score of -14.08. This is a bad value and indicates that ICU is not financially healthy and even has some risk of bankruptcy.
ICU's Altman-Z score of -14.08 is on the low side compared to the rest of the industry. ICU is outperformed by 83.24% of its industry peers.
There is no outstanding debt for ICU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.08
ROIC/WACCN/A
WACCN/A
ICU Yearly LT Debt VS Equity VS FCFICU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

ICU has a Current Ratio of 3.66. This indicates that ICU is financially healthy and has no problem in meeting its short term obligations.
ICU has a better Current ratio (3.66) than 64.32% of its industry peers.
ICU has a Quick Ratio of 3.64. This indicates that ICU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.64, ICU is in the better half of the industry, outperforming 72.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.64
ICU Yearly Current Assets VS Current LiabilitesICU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

5

3. Growth

3.1 Past

ICU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.67%, which is quite impressive.
The Revenue has grown by 1195.59% in the past year. This is a very strong growth!
EPS 1Y (TTM)86.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.18%
Revenue 1Y (TTM)1195.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%169.12%

3.2 Future

ICU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.09% yearly.
ICU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 128.68% yearly.
EPS Next Y91.82%
EPS Next 2Y39.39%
EPS Next 3Y25.09%
EPS Next 5YN/A
Revenue Next Year385.51%
Revenue Next 2Y182.33%
Revenue Next 3Y128.68%
Revenue Next 5YN/A

3.3 Evolution

ICU Yearly Revenue VS EstimatesICU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 500K 1M 1.5M 2M 2.5M
ICU Yearly EPS VS EstimatesICU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ICU. In the last year negative earnings were reported.
Also next year ICU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICU Price Earnings VS Forward Price EarningsICU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICU Per share dataICU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ICU's earnings are expected to grow with 25.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.39%
EPS Next 3Y25.09%

More info and screens

0

5. Dividend

5.1 Amount

ICU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (1/2/2026, 8:00:02 PM)

After market: 0.2697 +0.01 (+2.51%)

0.2631

+0.02 (+9.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-25 2026-03-25
Inst Owners3.03%
Inst Owner Change0%
Ins Owners0.75%
Ins Owner Change0.51%
Market Cap9.48M
Revenue(TTM)881.00K
Net Income(TTM)-13.66M
Analysts80
Price TargetN/A
Short Float %2.82%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.37%
Min EPS beat(2)14.19%
Max EPS beat(2)58.55%
EPS beat(4)3
Avg EPS beat(4)22.21%
Min EPS beat(4)-0.12%
Max EPS beat(4)58.55%
EPS beat(8)5
Avg EPS beat(8)3.4%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)19.9%
Min Revenue beat(2)-27.52%
Max Revenue beat(2)67.33%
Revenue beat(4)2
Avg Revenue beat(4)19.36%
Min Revenue beat(4)-55.78%
Max Revenue beat(4)93.4%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.38%
EPS NY rev (1m)0%
EPS NY rev (3m)18.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.77
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)-1.65
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.02
BVpS0.32
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -87.99%
ROE -119.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.35%
FCFM N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.66
Quick Ratio 3.64
Altman-Z -14.08
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.18%
EPS Next Y91.82%
EPS Next 2Y39.39%
EPS Next 3Y25.09%
EPS Next 5YN/A
Revenue 1Y (TTM)1195.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%169.12%
Revenue Next Year385.51%
Revenue Next 2Y182.33%
Revenue Next 3Y128.68%
Revenue Next 5YN/A
EBIT growth 1Y13.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.91%
OCF growth 3YN/A
OCF growth 5YN/A

SEASTAR MEDICAL HOLDING CORP / ICU FAQ

Can you provide the ChartMill fundamental rating for SEASTAR MEDICAL HOLDING CORP?

ChartMill assigns a fundamental rating of 3 / 10 to ICU.


What is the valuation status for ICU stock?

ChartMill assigns a valuation rating of 1 / 10 to SEASTAR MEDICAL HOLDING CORP (ICU). This can be considered as Overvalued.


What is the profitability of ICU stock?

SEASTAR MEDICAL HOLDING CORP (ICU) has a profitability rating of 1 / 10.


What is the expected EPS growth for SEASTAR MEDICAL HOLDING CORP (ICU) stock?

The Earnings per Share (EPS) of SEASTAR MEDICAL HOLDING CORP (ICU) is expected to grow by 91.82% in the next year.